SCHEMBL27898160

SCHEMBL27898160

CCOC(=O)OS(=O)(=O)c1ccc(N)c2ccccc12

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 5/20 0.42
▸ ALDH1A1 P00352 4/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ TTR P02766 1/20 0.40
▸ TSHR P16473 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ LMNA P02545 2/20 0.39
▸ GAA P10253 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ AHR P35869 1/20 0.38
▸ HSD11B1 P28845 1/20 0.36
▸ NSD2 O96028 2/20 0.35
▸ CYP4F2 P78329 1/20 0.35
▸ CYP4A11 Q02928 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28386954 0.78 CYP1A2 (0.53) HTT
SCHEMBL27797840 0.77 CDC25B (0.44) CDC25BALDH1A1HSD17B10SMN1; SMN2KDM4E
SCHEMBL27915736 0.76 CDC25B (0.41) CDC25BALDH1A1HSD17B10TTRTSHR
SCHEMBL2220408 0.74 TTR (0.41) CDC25BTTRNSD2
SCHEMBL111776 0.72 HSD11B1 (0.49) ALDH1A1TSHRSMN1; SMN2LMNAGAA
SCHEMBL5946756 0.70 ALDH1A1 (0.65) CDC25BALDH1A1HSD17B10TSHRSMN1; SMN2
SCHEMBL9241852 0.69 NSD2 (0.50) TTRTSHRSMN1; SMN2NSD2
SCHEMBL8839050 0.69 TTR (0.45) TTRNSD2
SCHEMBL28718534 0.69 TTR (0.45) ALDH1A1TTRSMN1; SMN2HSD11B1NSD2
SCHEMBL1525888 0.68 TTR (0.78) ALDH1A1HSD17B10TTRTSHRHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114751920-B Antitumor compounds 法马马有限公司 2024-06-07 — — CN disclosed
CN-114736219-B Antitumor compounds 法马马有限公司 2024-06-07 — — CN disclosed
CN-118139851-A Antitumor compounds 法马马有限公司 2024-06-04 — — CN disclosed
CN-117986153-A Ionizable cationic lipid compound, and preparation method and application thereof 晟迪生物医药(苏州)有限公司 2024-05-07 — — CN disclosed
CN-110650954-B anticancer compounds 法马马有限公司 2023-11-03 — — CN disclosed
CN-113226377-A Antibody drug conjugates comprising an eltrinastine derivative 法马马有限公司 2021-08-06 — — CN disclosed
CN-110650954-A Anticancer compounds 法马马有限公司 2020-01-03 — — CN disclosed
CN-103038240-A Synthetic method for preparing ecteinascidin compounds PHARMA MAR SA 2013-04-10 — — CN disclosed
Send feedback